SKRC39人肾乳头状细胞癌细 返回列表页

产品名称：SKRC39人肾乳头状细胞癌细胞、SKRC39人肾乳头状细胞癌细胞、SKRC39人肾乳头状细胞癌细胞、SKRC39人肾乳头状细胞癌细胞；


includes anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) antibodies, Monophosphoryl-lipid-A (MPLA), and an Indolamine-Dioxygenase-1 (IDO1) inhibitor. The aim of the study is, first, to rule out any major toxic eklects related to this therapy and, second, to assess